--The Two Revolutionary Brands Will
Redefine
Contraception Accessibility--
GRAND
RAPIDS, Mich. and NEW
YORK, April 9, 2024 /PRNewswire/ -- Today,
Perrigo Company plc, a leading provider of Consumer
Self-Care Products, announced that
Opill® — the first-ever daily birth control pill
available without a prescription in the U.S. — and the Women's
National Basketball Association (WNBA) have entered a multi-year
partnership that focuses on building confidence, strength and
health equity, all of which closely align with both organizations'
core priorities.
"Opill® is changing the game in reproductive health,
just like the WNBA's game-changing role in sports and pop culture,"
said Leila Bahbah, Perrigo U.S.
Women's Health Brand Lead. "Building upon our shared commitment to
foster equitable access and to increase health education, the goal
of this partnership is to prioritize dialogue and resources in
support of women's reproductive health."
Opill® will tip off the relationship as an Associate
Partner of the 2024 WNBA Draft presented by State Farm on
April 15 in Brooklyn, New York. Open to fans for the first
time since 2016, the Draft sold out in 15 minutes.
Opill®, too, recently celebrated a major milestone —
last month becoming the first over-the-counter daily birth control
pill to be available at most major retailers nationwide and
online.
"At the WNBA, we are committed to addressing issues that matter
to the players, and expanding access to reproductive healthcare is
one of those key issues," said Colie
Edison, WNBA Chief Growth Officer. "It's great to be working
with a partner whose values align and authentically integrates into
the health equity work our players are dedicated to."
This season, the WNBA is concentrating its social justice
efforts into two areas: civic engagement and reproductive health
advocacy. The league will take a multifaceted approach to spotlight
civic engagement initiatives, with a particular focus on
understanding how voting influences reproductive health matters
within communities of color.
Opill® and the WNBA are also collaborating on a
program to reach students on college campuses nationwide. At these
and other educational events, the two organizations will celebrate
those who are changing the game and educate millions of WNBA
fans about this new option, making contraception more accessible in
the U.S.
The Food and Drug Administration (FDA) approved
Opill® for OTC use without age restriction in
July 2023, and it became available
for purchase in March 2024. It is the
first-ever daily birth control pill available without a
prescription in the U.S. and is now available at pharmacies and
stores across the country as well as online and at Opill.com.
About Opill®
Opill® is the first ever and only daily
over-the-counter birth control pill available in the United States. It is a progestin-only
daily oral contraceptive that's safe and effective when used as
directed to help prevent pregnancy. Do not use Opill® if
you have or ever had breast cancer. See Opill® Drug
Facts label for full list of warnings. Opill® is
not an emergency contraceptive (morning after pill) and won't
prevent pregnancy when used after unprotected sex. It also doesn't
protect against HIV/AIDS or other sexually transmitted diseases
(STDs). For more information, please
visit www.opill.com or follow @opill_OTC on
Instagram, TikTok, Facebook, Threads and X.
About the WNBA
The WNBA is a bold, progressive basketball league that stands
for the power of women. Featuring 12 teams and entering its
28th season in 2024, the W is a unique sports property that
combines competition and entertainment with a commitment to
diversity, equity and inclusion and social responsibility. Through
its world-class athletes, the in-game fan experience, TV and
digital broadcasts, digital and social content, and community and
youth outreach programs, the league celebrates and elevates the
game of basketball and the culture around it. In 2020, the WNBA and
the Women's National Basketball Players Association (WNBPA) signed
a groundbreaking eight-year CBA that has charted a new course for
women's basketball — and women's sports overall — with a focus on
increased player compensation, improvements to the player
experience, expanded career development opportunities and resources
specifically tailored to the female professional athlete. Key
elements of the agreement are supported through the league's
partnership platform, the WNBA Changemakers Collective, with
AT&T, the WNBA's Marquee Partner and inaugural Changemaker, as
well as fellow inaugural Changemakers Deloitte and NIKE, Inc., and
subsequent additions Google, U.S. Bank and CarMax. During the 2020
season, the WNBA and WNBPA launched the WNBA Justice Movement,
forming the Social Justice Council with the mission of being a
driving force of necessary change and continuing work regarding
women's and maternal health and voting rights, among other
important societal issues.
About Perrigo
Perrigo Company plc is a leading provider
of Consumer Self-Care Products and
over-the-counter (OTC) health and wellness solutions that enhance
individual well-being by empowering consumers to proactively
prevent or treat conditions that can be self-managed. Visit Perrigo
online at www.perrigo.com.
Contact
Media:
All Opill®-related media inquiries to be directed to:
press@opill.com
WNBA
All WNBA-related media inquiries to be directed
to: stager@nba.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/opill-and-wnba-team-up-for-groundbreaking-partnership-302111916.html
SOURCE Perrigo Company plc